These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1134 related items for PubMed ID: 16824156

  • 21. Risk of de novo hepatitis in liver recipients from hepatitis-B core antibody-positive grafts - a systematic analysis.
    Skagen CL, Jou JH, Said A.
    Clin Transplant; 2011; 25(3):E243-9. PubMed ID: 21323735
    [Abstract] [Full Text] [Related]

  • 22. Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series.
    Huang YW, Liu CJ, Lai MY, Lee PH, Tsai MK, Wang SS, Lai MK, Kao JH.
    Clin Ther; 2006 Sep; 28(9):1327-34. PubMed ID: 17062306
    [Abstract] [Full Text] [Related]

  • 23. Use of hepatitis B core antibody-positive liver allograft in hepatitis C virus-positive and -negative recipients with use of short course of hepatitis B immunoglobulin and Lamivudine.
    Jain A, Orloff M, Abt P, Kashyap R, Mohanka R, Lansing K, Kelley M, Bozorgzadeh A.
    Transplant Proc; 2005 Sep; 37(7):3187-9. PubMed ID: 16213345
    [Abstract] [Full Text] [Related]

  • 24. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors.
    Dodson SF, Bonham CA, Geller DA, Cacciarelli TV, Rakela J, Fung JJ.
    Transplantation; 1999 Oct 15; 68(7):1058-61. PubMed ID: 10532552
    [Abstract] [Full Text] [Related]

  • 25. Dynamic alteration of HBV markers on active HBV replicative recipients after liver transplantation: a preliminary report.
    Lu SC, Yan LN, Li B, Ma YK, Liu C, Wen TF, Lin QY, Zhao JC, Wang XB, Li XD, Qing S, Zhao LS, Liu C, Liu J, Zhang XH.
    Hepatobiliary Pancreat Dis Int; 2003 May 15; 2(2):196-201. PubMed ID: 14599968
    [Abstract] [Full Text] [Related]

  • 26. [A study of the efficacy and safety of using hepatitis B surface antigen-positive donors for liver transplantation].
    Ju WQ, He XS, Wang DP, Deng RH, Wu LW, Guo ZY, Zhu XF, Huang JF.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Jan 15; 20(1):14-6. PubMed ID: 22464699
    [Abstract] [Full Text] [Related]

  • 27. Lamivudine prophylaxis for hepatitis B virus infection after lung transplantation.
    Shitrit AB, Kramer MR, Bakal I, Morali G, Ben Ari Z, Shitrit D.
    Ann Thorac Surg; 2006 May 15; 81(5):1851-2. PubMed ID: 16631684
    [Abstract] [Full Text] [Related]

  • 28. Safe use of livers from donors with positive hepatitis B core antibody.
    Manzarbeitia C, Reich DJ, Ortiz JA, Rothstein KD, Araya VR, Munoz SJ.
    Liver Transpl; 2002 Jun 15; 8(6):556-61. PubMed ID: 12037788
    [Abstract] [Full Text] [Related]

  • 29. Prevention of de novo hepatitis B infection from HbcAb-positive donors in living donor liver transplantation.
    Lee KW, Lee DS, Lee HH, Kim SJ, Joh JW, Seo JM, Choe YH, Lee SK.
    Transplant Proc; 2004 Oct 15; 36(8):2311-2. PubMed ID: 15561233
    [Abstract] [Full Text] [Related]

  • 30. Kidney transplantation from hepatitis B virus core antibody-positive donors: prophylaxis with hepatitis B immunoglobulin.
    Veroux M, Corona D, Ekser B, Giaquinta A, Tallarita T, De Martino C, Gentile F, Virgilio C, Gagliano M, Fiamingo P, Veroux P.
    Transplant Proc; 2011 May 15; 43(4):967-70. PubMed ID: 21620027
    [Abstract] [Full Text] [Related]

  • 31. De novo hepatitis b prophylaxis with hepatitis B virus vaccine and hepatitis B immunoglobulin in pediatric recipients of core antibody-positive livers.
    Lee S, Kim JM, Choi GS, Park JB, Kwon CH, Choe YH, Joh JW, Lee SK.
    Liver Transpl; 2016 Feb 15; 22(2):247-51. PubMed ID: 26600319
    [Abstract] [Full Text] [Related]

  • 32. Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection.
    Franchello A, Ghisetti V, Marzano A, Romagnoli R, Salizzoni M.
    Liver Transpl; 2005 Aug 15; 11(8):922-8. PubMed ID: 16035057
    [Abstract] [Full Text] [Related]

  • 33. Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors.
    Roque-Afonso AM, Feray C, Samuel D, Simoneau D, Roche B, Emile JF, Gigou M, Shouval D, Dussaix E.
    Gut; 2002 Jan 15; 50(1):95-9. PubMed ID: 11772974
    [Abstract] [Full Text] [Related]

  • 34. Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study.
    Angelico M, Nardi A, Marianelli T, Caccamo L, Romagnoli R, Tisone G, Pinna AD, Avolio AW, Fagiuoli S, Burra P, Strazzabosco M, Costa AN, Liver Match Investigators.
    J Hepatol; 2013 Apr 15; 58(4):715-23. PubMed ID: 23201239
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Liver transplantation with allografts from hepatitis B core antibody-positive donors: a new approach.
    Fábrega E, García-Suarez C, Guerra A, Orive A, Casafont F, Crespo J, Pons-Romero F.
    Liver Transpl; 2003 Sep 15; 9(9):916-20. PubMed ID: 12942452
    [Abstract] [Full Text] [Related]

  • 37. Twenty-four year single-center experience of hepatitis B virus infection in heart transplantation.
    Chen YC, Chuang MK, Chou NK, Chi NH, Wu IH, Chen YS, Yu HY, Huang SC, Wang CH, Tsao CI, Ko WJ, Wang SS.
    Transplant Proc; 2012 May 15; 44(4):910-2. PubMed ID: 22564582
    [Abstract] [Full Text] [Related]

  • 38. Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool.
    Loggi E, Micco L, Ercolani G, Cucchetti A, Bihl FK, Grazi GL, Gitto S, Bontadini A, Bernardi M, Grossi P, Costa AN, Pinna AD, Brander C, Andreone P.
    J Hepatol; 2012 Mar 15; 56(3):579-85. PubMed ID: 22027583
    [Abstract] [Full Text] [Related]

  • 39. Risks and treatment strategies for de novo hepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver transplantation.
    Dong C, Gao W, Ma N, Sun C, Zheng WP, Wang K, Shen ZY.
    Pediatr Transplant; 2017 Mar 15; 21(2):. PubMed ID: 27933716
    [Abstract] [Full Text] [Related]

  • 40. Adefovir is effective to promote development of immunity to donor origin hepatitis B virus in an allogeneic transplant recipient: a case report.
    Yaşar DG, Suyanı E, Özenirler S, Sucak GT.
    Transplant Proc; 2013 Mar 15; 45(2):833-4. PubMed ID: 23498831
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 57.